FDA 483 - Oscor Inc. - September 20, 2019
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of Oscor, Inc. in Palm Harbor, FL, revealed significant deficiencies in process validation and control procedures for medical device manufacturing. The firm failed to adequately validate critical processes like laser welding and adhesive drying, lacking scientific justification. Additionally, the inspection found that established process control procedures were not followed, including failures to report out-of-range energy readings and maintain proper documentation practices.
ID · 69fce441-8939-4a25-bcbf-51cfb31baa96